23-09-04	Analyst recommendations: Ergomed, Dollar general, Salesforce, Citigroup, Goldman Sachs...
22-11-17	FTSE 100 Closed Down 0.1% as U.K.'s New Fiscal -2-	DJ
22-11-17	Large UK Fiscal Tightening Could Reduce Need for -2-	DJ
22-08-04	Berenberg Starts Ergomed Coverage With Buy Rating	MT

More recommendations

News in other languages: Ergomed

23-09-06	Mandarine Europe Microcap " Un fonds vraiment Pan-Européen de Microcaps "
23-09-04	MIDDAY BRIEFING - Unternehmen und Märkte -2-
22-08-04	Bolsa de Madrid: La tecnología está cansada de ir cuesta abajo
22-08-04	Avis d'analystes du jour : HSBC, JCDecaux, Elior, Equasens, DiaSorin, TeamViewer, Just Eat, Interroll...
22-08-04	La "Tech" en a marre de baisser

More news

Managers and Directors: Ergomed

Manager	Title	Age	Since
Zubair Javeed CEO	Chief Executive Officer	54	2026-04-06
Nancy Maher CTO	Chief Tech/Sci/R&D Officer	-	2024-08-31
Sladana Sturlic CTO	Chief Tech/Sci/R&D Officer	-	1999-08-31

Director	Title	Age	Since
Zubair Javeed BRD	Director/Board Member	54	2025-12-18

More insiders

Ergomed PLC is a United Kingdom-based company that is primarily focused on providing specialized services to the biopharmaceutical industry. The Company operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). Its CRO segment is the process of developing medical therapies, drugs and knowledge for safe use in healthcare. Its PV segment is engaged in the activities relating to the detection, understanding and prevention of adverse effects or other drug-related problems throughout its lifecycle. The Company serves over 100 countries. It operates in North America, United Kingdom and Europe, Middle East and Africa, and Asia. The Companies subsidiaries include PrimeVigilance Inc., PrimeVigilance USA Inc., PrimeVigilance s.r.o., PharmInvent regulatory s.r.o., PrimeVigilance Japan K.K., Haemostatix Limited and Sound Opinion Limited.

Employees

1,500

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
ERGO Stock

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!

05-10	Ergomed Group Limited Announces Termination of Miroslav Reljanovic as Director Appointment, Effective April 29, 2026	CI
05-10	Ergomed Group Limited Appoints Alaric Richard Warwick Jackson as Director, Effective May 8, 2026	CI
12-22	Ergomed Group Limited Appoints Zubair Javeed as Director, Effective December 19, 2025	CI
24-10-04	Ergomed Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-10-01	CEL-SCI Corporation Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine in Head and Neck Cancer	CI
23-11-14	Ergomed Delists From London Stock Exchange	MT
23-11-12	Permira Advisers Ltd. completed the acquisition of Ergomed plc from Amati Global Investors Ltd. and others.	CI
23-11-09	Milton plans energy focus; Guild completes fund raise	AN
23-11-09	UK Court Clears Permira's Ergomed Purchase	MT
23-10-27	Ergomed says conditions satisfied for Permira takeover	AN
23-10-27	Permira's Takeover of Ergomed Nears Completion	MT
23-10-23	Ergomed's Takeover by Permira Advisers Expected to Take Effect mid-November	MT
23-10-13	Ergomed Shareholders Back Eden AcquisitionCo's Bid	MT

23-11-14	Ergomed strongly positioned for future growth in new partnership with Permira	GL
23-11-10	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR
23-10-27	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR
23-10-26	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR
23-10-25	Samson Rock Capital LLP - Form 8.3 - Ergomed Plc	PR

Date	Insider	Type	Main position	Quantity	% Market Cap.
23-06-15	Jonathan Curtain	Free	Chief Financial Officer	28,866	0.0568%
23-04-18	Miroslav Reljanovic	Others	Chief Executive Officer	400,000	0.7936%
22-12-04	Richard Timothy Barfield	Fiscal year	Chief Financial Officer	125,000	0.2492%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ERGOMED	-.--%	+0.15%	-	-	886M
ARGENX SE	+1.03%	+2.30%	+55.91%	+114.22%	56.42B
WUXI APPTEC CO., LTD.	+2.72%	+3.26%	+46.05%	+44.91%	44.54B
BIONTECH SE	+1.12%	+2.79%	-15.04%	-21.68%	22.9B
INSMED INCORPORATED	+1.17%	+3.85%	-0.89%	+403.86%	21.21B
WUXI BIOLOGICS (CAYMAN) INC.	+3.81%	-5.07%	+11.00%	-30.62%	16.4B
GENMAB A/S	+0.15%	+2.24%	+9.32%	-39.30%	15.4B
EXELIXIS, INC.	-0.69%	+0.82%	+27.75%	+176.72%	13.35B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+5.27%	+5.54%	+19.65%	-	12.36B
PHARMAESSENTIA CORPORATION	+1.61%	+1.28%	+95.75%	+205.26%	11.15B
Average	+1.62%	+2.09%	+27.72%	+106.67%	23.75B
Weighted average by Cap.	+1.72%	+2.37%	+32.04%	+99.60%

Ergomed Stock

Stocks

ERGO

GB00BN7ZCY67

Biotechnology & Medical Research

Latest news : Ergomed

Analysts' recommendations: Ergomed

Press Releases: Ergomed

News in other languages: Ergomed

Managers and Directors: Ergomed

Latest insider transactions

Bio Therapeutic Drugs

Company Profile